*Samples not available for some products.
SurModics offers a variety of microarray slides for customized DNA, RNA, and protein microarray development. CodeLink® and CodeLink® HD Activated Slides, and TRIDIA™ EP (Epoxy) Microarray Slides offer the precision, reproducibility, and sensitivity required for successful microarray applications and HTP screens. The key is SurModics' patented TRIDIA™ surface chemistry – a three-dimensional matrix comprised of three parts: a long-chain, hydrophilic passivating polymer, a reactive group, and photoreactive chemistry. The overall effect is a surface that can be covalently coupled to any substrate and that prevents nonspecific binding, while at the same time allowing for the homogenous coupling of different types of biomolecules, including DNA, RNA, protein, and cells. All of these slides are easy to use and are compatible with most available arraying equipment.
CodeLink® Activated Microarray Slides –
with a TRIDIA™ NHS Coating
Product Code DN01-0025 – formerly GE Healthcare #300011 (or #256700-00):
CodeLink® HD Activated Microarray Slides –
with a TRIDIA™ High-Density Coating
Product Code DHD1-0023 – formerly GE Healthcare #300051 (or #070071-00)
All of the above, plus:
TRIDIA™ EP Microarray Slides –
with a TRIDIA™ Epoxy Coating
Product Code DEPX-0025
Press Release: SurModics Acquires CodeLink Microarray Slide Business
User Guide: CodeLink Activated Slides User Guide
Product Brochure: "SurModics Microarray Products"
Product Brochure: "TRIDIA™ In Vitro Diagnostic Surfaces"
Activated Microarray Slides are not available for online ordering at this time. To place an order, or If you need additional information on our Activated Microarray Slides, please contact us.
CodeLink is a trademark of a GE Healthcare Company
TRIDIA is a trademark of SurModics, Inc.
SurModics’ slides may be suitable for the manufacture, use and/or analysis of oligonucleotide arrays, including uses covered under patents owned by Oxford Gene Technology Limited or related companies (“OGT”). However, SurModics is not licensed under any of these patents and does not have the right to pass on a license under any such patents to the end-user. Therefore the end-user of these slides should first check with OGT as to whether a license is necessary to manufacture, use, or analyze an oligonucleotide array and if so, secure one.
To inquire about a license under OGT’s oligonucleotide array patents, please contact licensing@ogt.co.uk. For information about OGT please visit its website at www.ogt.co.uk.